Major Estimate Revision • Jun 05
Consensus EPS estimates fall by 11%, revenue upgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast increased from US$2.93b to US$3.07b. EPS estimate fell from US$4.99 to US$4.43 per share. Net income forecast to grow 36% next year vs 26% growth forecast for Machinery industry in the US. Consensus price target of US$136 unchanged from last update. Share price fell 4.8% to US$87.95 over the past week. Annonce • Jun 03
ESAB Corporation announced that it has received $317.98507 million in funding On June 1, 2026, ESAB Corporation has closed the transaction. The preferred shares are convertible into common shares of the company at a conversion rate of Minimum 7.1806 and number of shares 1,256,605 and Maximum 8.2576 and number of shares 1,445,080. The Series A Mandatory Convertible Preferred Stock does not have a maturity date but will mandatorily convert into shares of the Company’s Common Stock on the mandatory conversion date, approximately three years after the initial issue date. Cumulative cash dividends on the Series A Mandatory Convertible Preferred Stock will be payable at a rate of 6.50% per annum (equivalent to $65.00 per annum per share), quarterly in arrears, when, as and if declared by the Company’s board of directors. Annonce • Jun 02
ESAB Corporation (NYSE:ESAB) completed the acquisition of Eddyfi Technologies from Novacap Management Inc., CDP Investissements Inc., INVESTISSEMENTS FLORIAN HARDY INC., PLACEMENTS MSR INC, 3ALPHA CAPITAL INC and others. ESAB Corporation (NYSE:ESAB) agreed to acquire Eddyfi Technologies from Novacap Management Inc., CDP Investissements Inc., INVESTISSEMENTS FLORIAN HARDY INC., PLACEMENTS MSR INC, 3ALPHA CAPITAL INC and others for $1.4 billion on January 31, 2026. A cash consideration of $1.45 billion will be paid by ESAB Corporation. As part of consideration, $1.45 billion is paid towards common equity of Eddyfi Technologies. The acquisition is expected to be funded with a combination of cash on hand, debt and $318 million of fully committed equity, The Company has obtained a commitment for a $1.0 billion 364-day senior unsecured bridge term loan credit facility from JPMorgan Chase Bank, N.A., which will be available to fund the cash consideration for the Acquisition and related fees and expenses. In case of termination of transaction, ESAB Corporation will pay a termination fee of $50.75 million.
As part of the transaction, ESAB has made firm commitments to maintain Eddyfi’s workforce and head office in Quebec City.
The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The transaction is expected to close in mid-2026.
Bennett Jones LLP acted as legal advisor for ESAB Corporation. Fasken Martineau DuMoulin LLP acted as legal advisor for CDP Investissements Inc. Blake, Cassels & Graydon LLP acted as legal advisor for Novacap Management Inc. McCarthy Tétrault LLP acted as legal advisor for Eddyfi Technologies. Ryan Bloom, Pim Kraaijeveld, Peter Magnone, Aqeel Shaukat, Arwen Ma of EC M&A acted as financial advisors for Eddyfi Technologies. Goldman Sachs Canada, Inc. acted as a financial advisor for Eddyfi Technologies.
ESAB Corporation (NYSE:ESAB) completed the acquisition of Eddyfi Technologies from Novacap Management Inc., CDP Investissements Inc., INVESTISSEMENTS FLORIAN HARDY INC., PLACEMENTS MSR INC, 3ALPHA CAPITAL INC and others on June 2, 2026. Actualités en direct • May 29
ESAB Faces Major Legal Uncertainty After South Carolina Court Ruling on Asbestos Liability South Carolina’s Supreme Court issued a decision in Tibbs v. Asbestos Corp. Limited that allows claims to continue seeking to hold Cape Intermediate Holdings Limited liable for historical raw asbestos sales.
The ruling clears the way for a trial in which a court-appointed receiver is attempting to hold ESAB Corp. responsible for asbestos liabilities through veil-piercing theories linked to Cape Intermediate Holdings.
If ESAB is ultimately found responsible for these asbestos liabilities, the company faces what has been described as an existential problem.
This development puts legal risk front and center for ESAB, since the outcome of the veil-piercing trial could materially affect its financial obligations and overall corporate structure.
Investors may want to pay close attention to the progress of this case, any disclosures from ESAB about potential liability ranges, and how the company addresses this risk in future filings and communications. Declared Dividend • May 13
First quarter dividend increased to US$0.12 Dividend of US$0.12 is 20% higher than last year. Ex-date: 2nd July 2026 Payment date: 17th July 2026 Dividend yield will be 0.5%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 10%. Cash payout ratio: 11%. Annonce • May 11
ESAB Corporation Increases Quarterly Cash Dividend, Payable on July 17, 2026 ESAB Corporation announced that its Board of Directors has declared an increased quarterly cash dividend of $0.12 per share of the Company’s common stock. The dividend is payable on July 17, 2026 to shareholders of record as of July 3, 2026. Buy Or Sell Opportunity • May 11
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 25% to US$101. The fair value is estimated to be US$126, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 7.9%. Revenue is forecast to grow by 6.1% in 2 years. Earnings are forecast to grow by 72% in the next 2 years. Reported Earnings • May 07
First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2026 results: EPS: US$0.82 (down from US$1.15 in 1Q 2025). Revenue: US$745.6m (up 9.9% from 1Q 2025). Net income: US$50.2m (down 28% from 1Q 2025). Profit margin: 6.7% (down from 10% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 6.0%. Earnings per share (EPS) missed analyst estimates by 37%. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Machinery industry in the US. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth. New Risk • May 07
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 13% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. This is currently the only risk that has been identified for the company. Annonce • Apr 10
ESAB Corporation to Report Q1, 2026 Results on May 07, 2026 ESAB Corporation announced that they will report Q1, 2026 results on May 07, 2026 Annonce • Mar 30
ESAB Corporation, Annual General Meeting, May 08, 2026 ESAB Corporation, Annual General Meeting, May 08, 2026. Upcoming Dividend • Mar 26
Upcoming dividend of US$0.10 per share Eligible shareholders must have bought the stock before 02 April 2026. Payment date: 17 April 2026. Payout ratio is a comfortable 9.2% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of American dividend payers (4.4%). Lower than average of industry peers (1.2%). Buy Or Sell Opportunity • Mar 05
Now 20% undervalued Over the last 90 days, the stock has risen 2.5% to US$113. The fair value is estimated to be US$143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 7.5% in 2 years. Earnings are forecast to grow by 51% in the next 2 years. Declared Dividend • Mar 02
Fourth quarter dividend of US$0.10 announced Shareholders will receive a dividend of US$0.10. Ex-date: 2nd April 2026 Payment date: 17th April 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 9%. Cash payout ratio: 11%. Annonce • Feb 27
ESAB Corporation Declares Quarterly Cash Dividend, Payable on April 17, 2026 ESAB Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the company’s common stock. The dividend is payable on April 17, 2026 to shareholders of record as of April 2, 2026. Recent Insider Transactions Derivative • Feb 24
President notifies of intention to sell stock Shyam Kambeyanda intends to sell 59k shares in the next 90 days after lodging an Intent To Sell Form on the 23rd of February. If the sale is conducted around the recent share price of US$130, it would amount to US$7.7m. For the year to December 2019, Shyam's total compensation was 13% salary and 87% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Shyam's direct individual holding has increased from 68.09k shares to 99.86k. Company insiders have collectively sold US$6.5m more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Feb 22
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: US$4.14 (down from US$4.73 in FY 2024). Revenue: US$2.84b (up 3.7% from FY 2024). Net income: US$251.4m (down 12% from FY 2024). Profit margin: 8.8% (down from 10% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 14%. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Machinery industry in the US. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions Derivative • Feb 10
Executive VP & CFO notifies of intention to sell stock Kevin Johnson intends to sell 3k shares in the next 90 days after lodging an Intent To Sell Form on the 6th of February. If the sale is conducted around the recent share price of US$135, it would amount to US$470k. Since March 2025, Kevin's direct individual holding has increased from 14.53k shares to 26.40k. Company insiders have collectively sold US$7.7m more than they bought, via options and on-market transactions in the last 12 months. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to US$134, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Machinery industry in the US. Total returns to shareholders of 127% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$128 per share. Recent Insider Transactions Derivative • Feb 07
Executive VP & CFO notifies of intention to sell stock Kevin Johnson intends to sell 3k shares in the next 90 days after lodging an Intent To Sell Form on the 6th of February. If the sale is conducted around the recent share price of US$135, it would amount to US$470k. Since March 2025, Kevin's direct individual holding has increased from 14.53k shares to 26.40k. Company insiders have collectively sold US$7.7m more than they bought, via options and on-market transactions in the last 12 months. Annonce • Feb 02
ESAB Corporation (NYSE:ESAB) agreed to acquire Eddyfi Technologies from Novacap Management Inc., CDP Investissements Inc., INVESTISSEMENTS FLORIAN HARDY INC., PLACEMENTS MSR INC, 3ALPHA CAPITAL INC. and others for $1.4 billion. ESAB Corporation (NYSE:ESAB) agreed to acquire Eddyfi Technologies from Novacap Management Inc., CDP Investissements Inc., INVESTISSEMENTS FLORIAN HARDY INC., PLACEMENTS MSR INC, 3ALPHA CAPITAL INC and others for $1.4 billion on January 31, 2026. A cash consideration of $1.45 billion will be paid by ESAB Corporation. As part of consideration, $1.45 billion is paid towards common equity of Eddyfi Technologies.
The acquisition is expected to be funded with a combination of cash on hand, debt and $318 million of fully committed equity, The Company has obtained a commitment for a $1.0 billion 364-day senior unsecured bridge term loan credit facility from JPMorgan Chase Bank, N.A., which will be available to fund the cash consideration for the Acquisition and related fees and expenses.
In case of termination of transaction, ESAB Corporation will pay a termination fee of $50.75 million.
As part of the transaction, ESAB has made firm commitments to maintain Eddyfi’s workforce and head office in Quebec City.
The transaction is subject to approval by regulatory board / committee and subject to antitrust regulations. The transaction is expected to close in mid-2026.
Bennett Jones LLP acted as legal advisor for ESAB Corporation. Fasken Martineau DuMoulin LLP acted as legal advisor for CDP Investissements Inc. Blake, Cassels & Graydon LLP acted as legal advisor for Novacap Management Inc. McCarthy Tétrault LLP acted as legal advisor for Eddyfi Technologies. Ryan Bloom, Pim Kraaijeveld, Peter Magnone, Aqeel Shaukat, Arwen Ma of EC M&A acted as financial advisors for Eddyfi Technologies. Upcoming Dividend • Dec 24
Upcoming dividend of US$0.10 per share Eligible shareholders must have bought the stock before 31 December 2025. Payment date: 16 January 2026. Payout ratio is a comfortable 8.0% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of American dividend payers (4.4%). Lower than average of industry peers (1.3%). Buy Or Sell Opportunity • Dec 18
Now 20% undervalued Over the last 90 days, the stock has risen 2.9% to US$113. The fair value is estimated to be US$142, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Declared Dividend • Dec 08
Third quarter dividend of US$0.10 announced Shareholders will receive a dividend of US$0.10. Ex-date: 31st December 2025 Payment date: 16th January 2026 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 8%. Cash payout ratio: 10%. Buy Or Sell Opportunity • Dec 02
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 3.7% to US$110. The fair value is estimated to be US$140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 5.7% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Buy Or Sell Opportunity • Nov 04
Now 21% undervalued Over the last 90 days, the stock has risen 2.2% to US$112. The fair value is estimated to be US$142, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 5.7% per annum. Earnings are also forecast to grow by 14% per annum over the same time period. Reported Earnings • Oct 30
Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2025 results: EPS: US$1.05 (down from US$1.14 in 3Q 2024). Revenue: US$727.8m (up 8.1% from 3Q 2024). Net income: US$63.7m (down 7.9% from 3Q 2024). Profit margin: 8.7% (down from 10% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Machinery industry in the US. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Oct 29
ESAB Corporation Raises Earnings Guidance for the Year 2025 ESAB Corporation raised earnings guidance for the year 2025. For the year, the company raises its outlook for total core sales growth of 4.5% to 5.5%, core organic sales growth of 1.0% from its prior outlook of total core sales growth of 1.5% to 3.5%, core organic sales growth of 0.0% to 2.0%. Annonce • Oct 09
ESAB Corporation to Report Q3, 2025 Results on Oct 29, 2025 ESAB Corporation announced that they will report Q3, 2025 results on Oct 29, 2025 Upcoming Dividend • Sep 29
Upcoming dividend of US$0.10 per share Eligible shareholders must have bought the stock before 03 October 2025. Payment date: 17 October 2025. Payout ratio is a comfortable 7.4% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of American dividend payers (4.4%). Lower than average of industry peers (1.5%). Declared Dividend • Sep 15
Second quarter dividend of US$0.10 announced Shareholders will receive a dividend of US$0.10. Ex-date: 3rd October 2025 Payment date: 17th October 2025 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 7%. Cash payout ratio: 9%. Buy Or Sell Opportunity • Sep 12
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 11% to US$110. The fair value is estimated to be US$139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.6% over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 11% per annum over the same time period. Annonce • Sep 12
ESAB Corporation Board Declares Quarterly Dividend, Payable on October 17, 2025 ESAB Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the Company’s common stock. The dividend is payable on October 17, 2025 to shareholders of record as of October 3, 2025. Recent Insider Transactions Derivative • Sep 10
Insider exercised options and sold US$512k worth of stock On the 5th of September, Michele Campion exercised 10.54k options at around US$41.79, then sold 7k of the shares acquired at an average of US$111 per share and kept the remainder. Since March 2025, Michele's direct individual holding has increased from 4.20k shares to 9.84k. Company insiders have collectively sold US$12m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Aug 07
President of Fabrication Technology exercised options and sold US$388k worth of stock On the 31st of July, Olivier Biebuyck exercised 4k options at a strike price of around US$46.94 and sold these shares for an average price of US$135 per share. This trade did not impact their existing holding. Since December 2024, Olivier's direct individual holding has increased from 5.99k shares to 14.99k. Company insiders have collectively sold US$12m more than they bought, via options and on-market transactions in the last 12 months. Buy Or Sell Opportunity • Aug 06
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 13% to US$109. The fair value is estimated to be US$137, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.6% over the last 3 years. Earnings per share has grown by 13%. For the next 3 years, revenue is forecast to grow by 3.1% per annum. Earnings are also forecast to grow by 11% per annum over the same time period. Annonce • Aug 06
ESAB Corporation Raises Earnings Guidance for the Year 2025 ESAB Corporation raised earnings guidance for the year 2025. For the year, company now expected total core sales growth of 1.5% to 3.5%, core organic sales growth of 0.0% to 2.0%, M&A of ~2.5% and FX of ~(1.0)% from its prior outlook of total core sales growth of (1.0)% to 1.5%, core organic sales growth of 0.0% to 2.0%, M&A of 2.0%-2.5% and FX of ~(3.0)%. Annonce • Jul 10
ESAB Corporation to Report Q2, 2025 Results on Aug 06, 2025 ESAB Corporation announced that they will report Q2, 2025 results on Aug 06, 2025 Upcoming Dividend • Jun 26
Upcoming dividend of US$0.10 per share Eligible shareholders must have bought the stock before 03 July 2025. Payment date: 18 July 2025. Payout ratio is a comfortable 6.6% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of American dividend payers (4.8%). Lower than average of industry peers (1.6%). Annonce • Jun 26
ESAB Corporation (NYSE:ESAB) agreed to acquire Ewm-Gmbh Elektrowerkstätten for approximately €280 million ESAB Corporation (NYSE:ESAB) agreed to acquire Ewm-Gmbh Elektrowerkstätten for approximately €280 million on June 26, 2025. A cash consideration of €275 million will be paid by ESAB Corporation. As part of consideration, €275 million is paid towards common equity of Ewm-Gmbh Elektrowerkstätten.
The acquisition will be funded through cash on hand. The transaction is subject to approval by regulatory board / committee. The expected completion of the transaction is in the second half of 2025. Recent Insider Transactions Derivative • May 16
President exercised options and sold US$1.4m worth of stock On the 12th of May, Shyam Kambeyanda exercised options to acquire 11k shares at no cost and sold these for an average price of US$129 per share. This trade did not impact their existing holding. For the year to December 2019, Shyam's total compensation was 13% salary and 87% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since December 2024, Shyam's direct individual holding has increased from 53.90k shares to 68.09k. Company insiders have collectively sold US$11m more than they bought, via options and on-market transactions in the last 12 months. Declared Dividend • May 12
First quarter dividend increased to US$0.10 Dividend of US$0.10 is 25% higher than last year. Ex-date: 3rd July 2025 Payment date: 18th July 2025 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 7%. Cash payout ratio: 7%. Annonce • May 09
ESAB Corporation Declares Quarterly Cash Dividend, Payable on July 18, 2025 ESAB Corporation announced that its Board of Directors has declared an increased quarterly cash dividend of $0.10 per share of the Company’s common stock. The dividend is payable on July 18, 2025 to shareholders of record as of July 3, 2025. Reported Earnings • May 02
First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2025 results: EPS: US$1.15 (up from US$1.01 in 1Q 2024). Revenue: US$678.1m (down 1.7% from 1Q 2024). Net income: US$70.1m (up 15% from 1Q 2024). Profit margin: 10% (up from 8.8% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) missed analyst estimates by 5.3%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Machinery industry in the US. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Annonce • May 01
ESAB Corporation Raises Earnings Guidance for the Full Year 2025 ESAB Corporation raised earnings guidance for the full year 2025. For the period, the company raises its full year 2025 outlook for total core sales growth of (1.0)% to 1.5%, core organic sales growth of 0.0% to 2.0%, M&A of 2.0% to 2.5% and FX of ~(3.0)% from its prior outlook of total core sales growth of (2.0)% to 0.0%, core organic sales growth of 0.0% to 2.0%, M&A of ~1.5% and FX of ~(3.5)%. Annonce • Apr 10
ESAB Corporation to Report Q1, 2025 Results on May 01, 2025 ESAB Corporation announced that they will report Q1, 2025 results on May 01, 2025 Annonce • Mar 31
ESAB Corporation, Annual General Meeting, May 08, 2025 ESAB Corporation, Annual General Meeting, May 08, 2025. Upcoming Dividend • Mar 28
Upcoming dividend of US$0.08 per share Eligible shareholders must have bought the stock before 04 April 2025. Payment date: 17 April 2025. Payout ratio is a comfortable 6.3% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of American dividend payers (4.6%). Lower than average of industry peers (1.7%). Declared Dividend • Mar 03
Fourth quarter dividend of US$0.08 announced Shareholders will receive a dividend of US$0.08. Ex-date: 4th April 2025 Payment date: 17th April 2025 Dividend yield will be 0.3%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 6%. Cash payout ratio: 6%. Annonce • Feb 28
ESAB Corporation Declares Quarterly Cash Dividend, Payable on April 17, 2025 ESAB Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.08 per share of the Company’s common stock. The dividend is payable on April 17, 2025, to shareholders of record as of April 4, 2025. Recent Insider Transactions Derivative • Feb 21
President exercised options and sold US$1.1m worth of stock On the 18th of February, Shyam Kambeyanda exercised options to acquire 8k shares at no cost and sold these for an average price of US$132 per share. This trade did not impact their existing holding. For the year to December 2019, Shyam's total compensation was 13% salary and 87% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Shyam's direct individual holding has decreased from 72.16k shares to 53.90k. Company insiders have collectively sold US$10m more than they bought, via options and on-market transactions in the last 12 months. Reported Earnings • Feb 20
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: US$4.73 (up from US$3.59 in FY 2023). Revenue: US$2.74b (down 1.2% from FY 2023). Net income: US$287.2m (up 33% from FY 2023). Profit margin: 11% (up from 7.8% in FY 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.8%. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Machinery industry in the US. Annonce • Jan 23
ESAB Corporation to Report Q4, 2024 Results on Feb 20, 2025 ESAB Corporation announced that they will report Q4, 2024 results on Feb 20, 2025 Declared Dividend • Dec 20
Third quarter dividend of US$0.08 announced Shareholders will receive a dividend of US$0.08. Ex-date: 31st December 2024 Payment date: 17th January 2025 Dividend yield will be 0.2%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 6%. Cash payout ratio: 6%. Annonce • Dec 18
ESAB Corporation Declares Quarterly Cash Dividend, Payable on January 17, 2025 ESAB Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.08 per share of the Company’s common stock. The dividend is payable on January 17, 2025 to shareholders of record as of December 31, 2024. Annonce • Nov 14
159 Plaintiffs Sue Cape, Anglo American, De Beer Group PLC, and ESAB Corp More than 150 plaintiffs have filed suit against Cape, PLC, its subsidiaries and global affiliates including Anglo American, De Beer Group PLC, and ESAB Corp., which imported and distributed carcinogenic asbestos in the United States for decades. The mass action lawsuit alleges that Cape and its subsidiaries are liable for diseases caused by asbestos exposure suffered by residents of the state and beyond. It includes plaintiffs suffering from asbestos-related illnesses, including mesothelioma and lung cancer, as well as the families of those who have died from exposure to the deadly carcinogen. According to the lawsuit, Cape led efforts in the U.S. to hide from consumers and its own employees the risks that it knew existed from the South African asbestos it processed. When asbestos-related lawsuits began surfacing in the 1970s, Cape took measures to shield itself from legal action by creating new entities and then fleeing the U.S. The lawsuit details how Cape set up an elaborate structure of affiliated companies in South Africa, the United Kingdom and the United States to avoid financial responsibility for the harm it knew it was causing. Since those companies and their insurers have failed to respond to lawsuits brought on behalf of those injured or killed by asbestos-related diseases, a South Carolina court has appointed a receiver to respond on their behalf. The case is Augustus A. Adams et al. v Cape PLC et al., No. 2024-CP-40-06639 in the Court of Common Pleas, County of Richland for the Fifth Judicial Circuit. Price Target Changed • Nov 01
Price target increased by 10% to US$128 Up from US$116, the current price target is an average from 9 analysts. New target price is approximately in line with last closing price of US$123. Stock is up 64% over the past year. The company is forecast to post earnings per share of US$4.59 for next year compared to US$3.59 last year. Reported Earnings • Oct 29
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Third quarter 2024 results: EPS: US$1.14 (up from US$0.98 in 3Q 2023). Revenue: US$673.3m (down 1.1% from 3Q 2023). Net income: US$69.5m (up 18% from 3Q 2023). Profit margin: 10% (up from 8.6% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) also surpassed analyst estimates by 2.4%. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Machinery industry in the US. 